0001104659-21-056732.txt : 20210428 0001104659-21-056732.hdr.sgml : 20210428 20210428201829 ACCESSION NUMBER: 0001104659-21-056732 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210427 FILED AS OF DATE: 20210428 DATE AS OF CHANGE: 20210428 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SQUINTO STEPHEN P CENTRAL INDEX KEY: 0001231954 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39044 FILM NUMBER: 21866543 MAIL ADDRESS: STREET 1: C/O ALEXION PHARMACEUTICALS INC STREET 2: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06410 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SpringWorks Therapeutics, Inc. CENTRAL INDEX KEY: 0001773427 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 203-883-9490 MAIL ADDRESS: STREET 1: 100 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06902 4 1 tm2114187d3_4.xml FORM 4 X0306 4 2021-04-27 0 0001773427 SpringWorks Therapeutics, Inc. SWTX 0001231954 SQUINTO STEPHEN P C/O SPRINGWORKS THERAPEUTICS, INC. 100 WASHINGTON BLVD. STAMFORD, CT 06902 1 0 1 0 Common Stock 2021-04-27 4 S 0 201 75.0498 D 144959 D Common Stock 2021-04-28 4 S 0 19231 76.2018 D 125728 D The sale transaction reported on this Form 4 was effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $75.00 to $75.10, inclusive. Includes shares of common stock held by a trust (i) the beneficiaries of which are the Reporting Person's children and (ii) of which the Reporting Person is the trustee. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $75.00 to $77.72, inclusive. /s/ Francis I. Perier, Jr as Attorney-in-Fact 2021-04-28